Amidst the global surgical robotics sector's accelerated return to the essence of ultra-minimally invasive care, Beijing Shurui Robotics Co., Ltd., China's leading surgical robotics innovator, globally debuted its groundbreaking Variable Orifice Technology and the Ultra-Minimally Invasive Surgical Innovation Platform "Shurui^® S+suite" at the 91st China International Medical Equipment Fair (CMEF) on April 8, 2025.

As a China-originated ultra-minimally invasive surgical technology platform, the Shurui^® S+suite demonstrates exceptional performance in system responsiveness, control precision, and clinical adaptability. The launch of this platform marks a historic leap for China's high-end medical equipment sector—transitioning from "technology catch-up" to technology-defining capabilities.

Anchored by its fully proprietary serpentine-arm technology, this breakthrough dismantles the long-standing technological monopoly of international giants in minimally invasive surgical robotics. It propels global surgery into the "Single-Port PLUS" Smart Era, showcasing China's innovative prowess in premium medical technology to the global healthcare market.

Academy Recognition: China's Indigenous Innovation Earns Expert Acclaim
Professor Zhang Xu, Academician of the Chinese Academy of Sciences and a leading urologist, demonstrated the Shurui^® Serpentine-arm Surgical Robot during the conference and praised: "Remarkable! A national pride!"

Shurui Serpentine-arm Surgical Robot: Unlimited Access, Infinite Potential
From traditional open surgery to multi-port laparoscopy, then to single-port, natural orifice, and non-invasive techniques – each paradigm shift advances toward "smaller incisions and faster recovery." Single-port laparoscopy has been regarded as the critical pathway to the ultra-minimally invasive era, yet achieving complex, high-precision operations through a single confined incision remains a global challenge.

Historically, international medical giants dominated the market through multi-port robotic systems fortified by technological barriers and patent fortresses. Chinese innovators, despite relentless efforts, struggled to escape the shadow of derivative innovation.

Breaking this paradigm, Shurui^® has pioneered an autonomous technological route. By fundamentally reengineering surgical approaches through its proprietary Serpentine-arm Technology, the system not only delivers true single-port ultra-minimally invasive capabilities but elevates robotic surgery to new dimensions – achieving the ultimate equilibrium between minimal trauma and maximal therapeutic efficacy.

Currently deployed across urology, gynecology, general surgery, thoracic surgery, pediatric surgery, head & neck surgery, and thyroid/breast specialties, the system has achieved:40+ internationally/

domestically pioneered surgical breakthroughs Single-port execution of traditionally multi-port-dependent complex procedures through its serpentine-arm technology
Continuous redefinition of single-port surgery's clinical frontiers.

World's First Serpentine-arm Surgical Robot with Variable Orifice Technology and S+suite Innovation Platform Launched

At CMEF, Shurui^® Robotics unveiled its globally pioneering Variable Orifice Technology for serpentine-arm surgical robots, redefining surgical access design with unprecedented procedural freedom. This modular system enables seamless transitions between single-port, multi-port, and hybrid approaches, accelerating the global adoption of ultra-minimally invasive techniques.

Shurui^® CEO Zhao Lei stated: "The S+suite platform signifies our transition from technological catch-up to innovation leadership in ultra-minimally invasive surgery." Currently pursuing CE Mark certification, the platform will collaborate with global top-tier hospitals to establish a single-port surgical database, positioning Chinese standards as international benchmarks.

Triple-Core S+suite Platform Architecture:SRS Ultra-Low Latency Telesurgery System,SE Multi-energy Coagulation/Cutting Tool, S-Center Translational Medicine Hub.

Milestone 1: SRS Ultra-Low Latency Telesurgery System

While global competitors debate telesurgery feasibility, Shurui^® has already executed a transcontinental lung cancer resection spanning 8,000 kilometers between China and Europe – a collaboration between Prof. Diego González Rivas (Spain) and Prof. Zhao Jun's team (Suzhou University Affiliated Hospital). This European debut follows landmark achievements: World's first military telesurgery (Prof. Wang Linhui, Changhai Hospital), Tri-site rotational telesurgery (Prof. Ji Mei, Zhengzhou University Hospital), Pioneering China-US cross-Pacific procedure

Powered by the SURG BOXES ultra-low latency platform (<100ms), Shurui^® enables borderless high-precision surgical resource distribution.

Milestone 2: SE Multi-energy Coagulation/Cutting Tool

Addressing the "final frontier" of single-port robotics, the SE Tool delivers: Dual-energy integration: Combines bipolar precision with monopolar efficiency Omni-articulation: 360° maneuverability via serpentine-arm synergy Cost-optimized reusability: Eliminates disposable instrument wasteThis breakthrough resolves longstanding limitations of robotic energy devices: inflexible shaft design, prohibitive costs, and operational incompatibility.

Milestone 3: S-Center Translational Medicine Hub
Co-developed with national research infrastructures, this clinical demand-driven platform features: Surgeon-engineer co-creation labs,  Real-world evidence acceleration pipelines, Continuous clinical optimization protocols. Over 120 hospitals currently leverage its rapid technology iteration capabilities.

Pioneering Boundless Horizons for Global Healthcare

From Technological Follower to Industry Architect, Shurui^®’s Variable Orifice Technology and S+suite platform, anchored by its proprietary Serpentine-Arm Technology, are revolutionizing the fundamental paradigms of surgical practice. This transcends mere robotic arm advancement – it embodies China’s intellectual redefinition of global healthcare standards.

By shattering technological monopolies through indigenous innovation, Shurui^® harmonizes cutting-edge engineering with human-centric care. Through China-originated benchmarks, the company is forging a new epoch in international medicine, unlocking boundless possibilities for human health.